| Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery (NCT03678350) | Roswell Park Cancer Institute | 2021-09-17 |
| Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma (NCT04173338) | Augusta University | 2020-01-23 |
| Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours (NCT03852823) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-05-23 |
| Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery (NCT03007030) | M.D. Anderson Cancer Center | 2017-04-05 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso (NCT02580747) | Chinese PLA General Hospital | 2015-10-01 |
| Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers (NCT02349412) | Alliance for Clinical Trials in Oncology | 2015-06-25 |
| A Study of LY3023414 in Participants With Advanced Cancer (NCT01655225) | Eli Lilly and Company | 2012-07-31 |
| The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma (NCT01655888) | Azienda Ospedaliera Universitaria Senese | 2012-07-01 |
| Rehabilitation by Effort for Patients With Advanced Bronchial Cancer (NCT03684486) | University Hospital, Toulouse | 2012-02-01 |
| Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients (NCT02300883) | Armando Santoro, MD | 2011-04-01 |
| Dendritic Cell Vaccination for Patients with Solid Tumors (NCT01291420) | University Hospital, Antwerp | 2010-05-03 |
| Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy (NCT01085630) | Alliance for Clinical Trials in Oncology | 2010-04-01 |
| A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma (NCT01649024) | Azienda Ospedaliera Universitaria Senese | 2009-05-01 |
| S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery (NCT00770120) | SWOG Cancer Research Network | 2008-12-01 |
| Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease (NCT00733252) | Case Comprehensive Cancer Center | 2008-04-01 |
| Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma (NCT00509041) | Alliance for Clinical Trials in Oncology | 2007-08-01 |
| Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery (NCT00541073) | Centre Oscar Lambret | 2007-06-01 |
| Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia (NCT00899613) | University Hospital, Caen | 2007-04-01 |
| Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma (NCT00458913) | European Organisation for Research and Treatment of Cancer - EORTC | 2007-02-01 |
| Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma (NCT00398138) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma (NCT00634205) | European Lung Cancer Working Party | 2006-07-01 |
| Bortezomib in Treating Patients With Malignant Pleural Mesothelioma (NCT00513877) | Cancer Trials Ireland | 2006-05-01 |
| Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer (NCT00372840) | Fox Chase Cancer Center | 2006-05-01 |
| Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma (NCT00334594) | Swiss Cancer Institute | 2005-11-14 |
| Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107 (NCT00898547) | Alliance for Clinical Trials in Oncology | 2005-11-01 |
| Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma (NCT00227630) | European Organisation for Research and Treatment of Cancer - EORTC | 2005-07-01 |
| Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery (NCT00253409) | Institute of Cancer Research, United Kingdom | 2005-05-01 |
| Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma (NCT00075699) | Medical Research Council | 2003-09-01 |
| Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma (NCT00821860) | Papworth Hospital NHS Foundation Trust | 2003-09-01 |
| PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma (NCT00053885) | Alliance for Clinical Trials in Oncology | 2003-07-01 |
| Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors (NCT00066651) | National Cancer Institute (NCI) | 2003-07-01 |
| Alanosine in Treating Patients With Cancer (NCT00062283) | Memorial Sloan Kettering Cancer Center | 2003-03-01 |
| Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma (NCT00354393) | The Cleveland Clinic | 2002-08-01 |
| Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma (NCT00017186) | Alliance for Clinical Trials in Oncology | 2001-07-01 |
| Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma (NCT00027508) | PharmaMar | 2001-07-01 |
| Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer (NCT00024271) | Herbert Irving Comprehensive Cancer Center | 2001-05-01 |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer (NCT00006981) | National Cancer Institute (NCI) | 2000-12-01 |
| Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma (NCT00030459) | British Thoracic Society | 2000-11-01 |
| Capecitabine in Treating Patients With Malignant Mesothelioma (NCT00004183) | Alliance for Clinical Trials in Oncology | 2000-11-01 |
| SU5416 in Treating Patients With Malignant Mesothelioma (NCT00006014) | National Cancer Institute (NCI) | 2000-08-01 |
| Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung (NCT00030745) | Swiss Cancer Institute | 2000-06-01 |
| Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs (NCT00020124) | National Institutes of Health Clinical Center (CC) | 2000-06-01 |
| Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer (NCT00024076) | Jonsson Comprehensive Cancer Center | 2000-05-01 |
| Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura (NCT00004920) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-11-01 |
| Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed (NCT00004254) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-11-01 |
| Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery (NCT00005636) | Memorial Sloan Kettering Cancer Center | 1999-11-01 |
| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura (NCT00019825) | National Cancer Institute (NCI) | 1999-10-01 |
| Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma (NCT00054002) | Roswell Park Cancer Institute | 1999-03-01 |
| S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery (NCT00003723) | SWOG Cancer Research Network | 1999-02-01 |
| Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma (NCT00004033) | NYU Langone Health | 1998-09-01 |
| Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma (NCT00006231) | University of Glasgow | 1998-02-01 |
| Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma (NCT00003974) | Roswell Park Cancer Institute | 1997-08-01 |
| Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma (NCT00006216) | Louisiana State University Health Sciences Center in New Orleans | 1997-08-01 |
| ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen (NCT00003034) | Alfacell | 1997-05-01 |
| Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma (NCT00003263) | Fox Chase Cancer Center | 1996-08-01 |
| Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma (NCT00003508) | Burzynski Research Institute | 1996-03-08 |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors (NCT00002608) | Ottawa Regional Cancer Centre | 1994-05-01 |
| Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442) | Gynecologic Oncology Group | 1992-06-01 |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer (NCT00002475) | St. Vincent Medical Center - Los Angeles | 1991-04-01 |
| High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma (NCT00002465) | St. Vincent Medical Center - Los Angeles | 1987-12-01 |
| Tazemetostat Expanded Access Program for Adults With Solid Tumors (NCT03874455) | Epizyme, Inc. | |